Qube Research & Technologies LTD Annexon, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Annexon, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 447,700 shares of ANNX stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
447,700
Previous 14,806
2923.77%
Holding current value
$3.24 Million
Previous $106,000
1968.87%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ANNX
# of Institutions
157Shares Held
101MCall Options Held
3.61MPut Options Held
1.08M-
Bain Capital Life Sciences Investors, LLC Boston, MA8.45MShares$61.1 Million8.47% of portfolio
-
Satter Management Co., L.P.7.41MShares$53.5 Million71.21% of portfolio
-
Bvf Inc San Francisco, CA7MShares$50.6 Million1.05% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$47.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.43MShares$46.5 Million2.05% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $344M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...